心臓マーカーラピッドテスト&ポイントオブケア(POC):医療機器パイプライン分析

◆英語タイトル:Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0212
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:130
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥848,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,272,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Cardiac Markers Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Cardiac Markers Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2019″ provides an overview of Cardiac Markers Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Rapid Tests & Point of Care (POC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiac Markers Rapid Tests & Point of Care (POC) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Markers Rapid Tests & Point of Care (POC) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Markers Rapid Tests & Point of Care (POC) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 10
2.1 Cardiac Markers Rapid Tests & Point of Care (POC) Overview 10
3 Products under Development 11
3.1 Cardiac Markers Rapid Tests & Point of Care (POC) – Pipeline Products by Stage of Development 11
3.2 Cardiac Markers Rapid Tests & Point of Care (POC) – Pipeline Products by Segment 12
3.3 Cardiac Markers Rapid Tests & Point of Care (POC) – Pipeline Products by Territory 13
3.4 Cardiac Markers Rapid Tests & Point of Care (POC) – Pipeline Products by Regulatory Path 14
3.5 Cardiac Markers Rapid Tests & Point of Care (POC) – Pipeline Products by Estimated Approval Date 15
4 Cardiac Markers Rapid Tests & Point of Care (POC) – Pipeline Products under Development by Companies 16
4.1 Cardiac Markers Rapid Tests & Point of Care (POC) Companies – Pipeline Products by Stage of Development 16
4.2 Cardiac Markers Rapid Tests & Point of Care (POC) – Pipeline Products by Stage of Development 19
5 Cardiac Markers Rapid Tests & Point of Care (POC) Companies and Product Overview 22
5.1 1Drop Diagnostics Company Overview 22
5.1.1 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 22
5.2 Abbott Point of Care Inc Company Overview 23
5.2.1 Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Accel Diagnostics LLC Company Overview 24
5.3.1 Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 Akers Biosciences Inc Company Overview 25
5.4.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Akrivis Technologies LLC Company Overview 26
5.5.1 Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Alfa Wassermann Inc Company Overview 27
5.6.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Angle Biosciences Inc Company Overview 29
5.7.1 Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Anteo Diagnostics Ltd Company Overview 30
5.8.1 Anteo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 Atonomics A/S Company Overview 31
5.9.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Axis-Shield Diagnostics Ltd Company Overview 33
5.10.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
5.11 BBB Technologies Inc Company Overview 34
5.11.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34
5.12 Bio-AMD Inc Company Overview 35
5.12.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 BioMedomics Inc Company Overview 38
5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 BiOracle Ltd (Inactive) Company Overview 39
5.14.1 BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 Biosensia Ltd Company Overview 40
5.15.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 Biostealth, Inc. Company Overview 41
5.16.1 Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 Biosurfit, SA Company Overview 42
5.17.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 Brava Diagnostics Company Overview 43
5.18.1 Brava Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 Carclo Diagnostic Solutions Ltd Company Overview 44
5.19.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 CardioGenics Inc Company Overview 45
5.20.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Cordex Systems, LLC Company Overview 46
5.21.1 Cordex Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 46
5.22 Coris BioConcept Company Overview 47
5.22.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 47
5.23 Critical Diagnostics Company Overview 48
5.23.1 Critical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 48
5.24 Diazyme Laboratories Inc Company Overview 49
5.24.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 49
5.25 DSC Technologies Inc Company Overview 50
5.25.1 DSC Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 50
5.26 Duke University Company Overview 51
5.26.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 51
5.27 Dynasil Corporation of America Company Overview 53
5.27.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview 53
5.28 Edan Instruments Inc Company Overview 54
5.28.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 54
5.29 Epinex Diagnostics Inc Company Overview 57
5.29.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.30 ET Healthcare Inc Company Overview 58
5.30.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 58
5.31 Group K Diagnostics Company Overview 61
5.31.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 61
5.32 LeukoDx Ltd Company Overview 63
5.32.1 LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 63
5.33 MML Ltd Company Overview 64
5.33.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 64
5.34 Nanomix Inc Company Overview 66
5.34.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 66
5.35 Novartis AG Company Overview 68
5.35.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 68
5.36 Ohmx Corp Company Overview 69
5.36.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 69
5.37 OPKO Health Inc Company Overview 73
5.37.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 73
5.38 Prolight Diagnostics AB Company Overview 75
5.38.1 Prolight Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 75
5.39 QLIDA Diagnostics Company Overview 76
5.39.1 QLIDA Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 76
5.40 QuickCheck Health Inc Company Overview 77
5.40.1 QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview 77
5.41 Quidel Corp Company Overview 78
5.41.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 78
5.42 Radiometer Medical ApS Company Overview 79
5.42.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview 79
5.43 Radisens Diagnostics Ltd Company Overview 80
5.43.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
5.44 Resdin Technologies Inc. Company Overview 81
5.44.1 Resdin Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.45 Sandia National Laboratories Company Overview 82
5.45.1 Sandia National Laboratories Pipeline Products & Ongoing Clinical Trials Overview 82
5.46 Sarissa-Biomedical Ltd Company Overview 85
5.46.1 Sarissa-Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
5.47 Selfa, Inc. Company Overview 86
5.47.1 Selfa, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
5.48 SpinChip Diagnostics AS Company Overview 87
5.48.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 87
5.49 Thermo Fisher Scientific Inc Company Overview 88
5.49.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 88
5.50 ThreeFold Sensors (Inactive) Company Overview 89
5.50.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 89
5.51 Trinity Biotech Plc Company Overview 90
5.51.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 90
5.52 True Diagnostics Inc Company Overview 93
5.52.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 93
5.53 Universal Biosensors Inc Company Overview 94
5.53.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview 94
5.54 University of Vermont Company Overview 95
5.54.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview 95
5.55 Upstream Medical Technologies Ltd Company Overview 96
5.55.1 Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 96
5.56 XCellCure, LLC Company Overview 105
5.56.1 XCellCure, LLC Pipeline Products & Ongoing Clinical Trials Overview 105
6 Cardiac Markers Rapid Tests & Point of Care (POC) – Recent Developments 108
6.1 Oct 23, 2019: bioMerieux – Third-Quarter 2019 Business Review 108
6.2 Oct 22, 2019: bioMerieux – Third quarter 2019 business review 109
6.3 Oct 16, 2019: Trinity Biotech announces results for Q3, 2019 111
6.4 Sep 04, 2019: bioMerieux announces First-Half 2019 Results 112
6.5 Aug 20, 2019: Trinity Biotech announces results for Q2, 2019 115
6.6 May 07, 2019: Trinity Biotech announces results for Q1, 2019 117
6.7 Apr 24, 2019: bioMerieux: First-quarter 2019 business review 119
6.8 Mar 07, 2019: Trinity Biotech announces quarter 4 and fiscal year 2018 financial results 120
6.9 Feb 27, 2019: bioMerieux – 2018 Financial Results 122
6.10 Jan 25, 2019: Introducing DiaSys’ new CEO Dr. Jan Gorka 126
6.11 Dec 07, 2018: Quidel comments on California court ruling 126
7 Appendix 127
7.1 Methodology 127
7.2 About GlobalData 130
7.3 Contact Us 130
7.4 Disclaimer 130

List of Tables
Table 1: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 13
Table 2: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment 14
Table 3: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 15
Table 4: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 16
Table 5: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 17
Table 6: Cardiac Markers Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 18
Table 7: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 21
Table 8: 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 24
Table 9: One Drop Diagnostic Device - Cardiovascular Disease - Product Status 24
Table 10: One Drop Diagnostic Device - Cardiovascular Disease - Product Description 24
Table 11: Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 12: i-STAT TnI-Nx - Product Status 25
Table 13: i-STAT TnI-Nx - Product Description 25
Table 14: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 26
Table 15: pScreen BNP - Product Status 26
Table 16: pScreen BNP - Product Description 26
Table 17: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 18: Diagnostic Test - Heart Attack - Product Status 28
Table 19: Diagnostic Test - Heart Attack - Product Description 28
Table 20: Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 30
Table 21: Z-TECT - cTnI Assay - Product Status 30
Table 22: Z-TECT - cTnI Assay - Product Description 30
Table 23: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 24: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Status 31
Table 25: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Description 31
Table 26: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Status 32
Table 27: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Description 32
Table 28: Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 29: Cardiac Troponin Biomarker Kit - Product Status 33
Table 30: Cardiac Troponin Biomarker Kit - Product Description 33
Table 31: Anteo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
Table 32: AtomoRapid - Heart Attack - Product Status 34
Table 33: AtomoRapid - Heart Attack - Product Description 34
Table 34: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 36
Table 35: Premium Trace - B-type Natriuretic Peptide Assay - Product Status 36
Table 36: Premium Trace - B-type Natriuretic Peptide Assay - Product Description 36
Table 37: Trace - D-dimer Test - Product Status 37
Table 38: Trace - D-dimer Test - Product Description 37
Table 39: Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
Table 40: Afinion hsCRP Assay - Product Status 38
Table 41: Afinion hsCRP Assay - Product Description 38
Table 42: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 43: Mobile RDT Reader - Troponin-I Test - Product Status 39
Table 44: Mobile RDT Reader - Troponin-I Test - Product Description 39
Table 45: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 46: Digital Strip Reader - Cardiac Marker Test - Product Status 41
Table 47: Digital Strip Reader - Cardiac Marker Test - Product Description 41
Table 48: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Status 42
Table 49: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Description 42
Table 50: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Status 42
Table 51: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Description 44
Table 52: Magnetic Immunoassay Detection System - CK MB - Product Status 44
Table 53: Magnetic Immunoassay Detection System - CK MB - Product Description 44
Table 54: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 55: Point of Care Test - Troponin - Product Status 45
Table 56: Point of Care Test - Troponin - Product Description 45
Table 57: BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46
Table 58: biO1042 Test - Product Status 46
Table 59: biO1042 Test - Product Description 46
Table 60: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

List of Figures
Figure 1: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 11
Figure 2: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment 12
Figure 3: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 13
Figure 4: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 14
Figure 5: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 15

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心臓マーカーラピッドテスト&ポイントオブケア(POC):医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆